Non-invasive Solution for Periodontal and Peri-implant Diseases (INPERIO)

Launched by NANOKER RESEARCH S.L. · Jun 5, 2019

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Males/females of age 18-80.
• • Availability for the 18 months duration of the clinical trial.
• • Subject able and willing to follow study procedures and instructions.
• • Subject read, understood and signed an informed consent form.
• * Participants in need of dental implant treatment and that meet one of the following criteria:
• • Moderate to advanced periodontitis.
• • History of dental loss attributed to periodontitis.
• • Risk factors associated with periodontitis (tobacco consumption, poor oral hygiene, diabetes patients outside of the ideal range control (HbA1c \<7)).
• • Good general health at time of inclusion.
• • Subjects willing to disclose information on medication.
• Exclusion Criteria:
• • Female patients who report being pregnant or lactating, or who are of childbearing potential and are not using hormonal, barrier methods of birth control or abstinence.
• • Subject chronically treated (≥ two weeks) with any medication known to affect inflammation or periodontal status six months prior to enrollment or during the study.
• • Subject necessitating antibiotic for 1 month during the study.
• • Gross oral pathology.
• • Participation in any other clinical study or test panel within one month prior to entry into the study.
• • History of neoplastic disease requiring the use of chemotherapy.
• • Patients with history of renal failure or chronic renal diseases.
• • Patients affected by chronic liver diseases.
• • Patients with severe or uncontrolled metabolic bone disorders.
• • Conditions or circumstances, in the opinion of the investigator, which could represent a general contra-indication for undergoing surgery, or could prevent study completion or interfere with the analysis of the results, such as a history of non-compliance or unreliability.
• • History of local radiation therapy.